Since our findings support the role of TMEPAI as a potent negative regulator of PTEN tumor suppressor, thus emerging as a potential oncogenic marker in breast cancer, we next conducted a comprehensive expression analysis of TMEPAI and PTEN in TNBC tumors and surrounding normal/benign tissues by IHC. This evidence concerns the gene PMEPA1 and neoplasm.